TFS Capital’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-8,222
Closed -$216K 559
2017
Q2
$216K Buy
+8,222
New +$202K 0.08% 424
2017
Q1
Sell
-8,066
Closed -$203K 979
2016
Q4
$203K Sell
8,066
-1,793
-18% -$45.3K 0.05% 529
2016
Q3
$277K Sell
9,859
-67,307
-87% -$1.73M 0.07% 437
2016
Q2
$1.9M Buy
+77,166
New +$1.91M 0.35% 22
2016
Q1
Sell
-32,498
Closed -$1.14M 1187
2015
Q4
$1.14M Buy
32,498
+12,266
+61% +$384K 0.12% 286
2015
Q3
$576K Sell
20,232
-11,455
-36% -$385K 0.06% 481
2015
Q2
$1.05M Sell
31,687
-7,090
-18% -$218K 0.1% 318
2015
Q1
$1.09M Buy
38,777
+26,207
+208% +$651K 0.11% 318
2014
Q4
$260K Buy
+12,570
New +$298K 0.02% 765
2014
Q2
Sell
-61,209
Closed -$1.71M 1504
2014
Q1
$1.71M Sell
61,209
-245,235
-80% -$6.02M 0.11% 263
2013
Q4
$6.59M Buy
306,444
+122,409
+67% +$2.23M 0.31% 59
2013
Q3
$2.44M Sell
184,035
-41,358
-18% -$557K 0.11% 266
2013
Q2
$3.12M Buy
+225,393
New +$3.19M 0.13% 206

Other funds holding PMC

TFS Capital's PMC Position: Q3 2017 in Review

TFS Capital sold out of PharMerica Corporation (PMC) in Q3 2017, closing a stake of 8,222 shares — an estimated $216K sold.

TFS Capital first reported a position in PMC in Q2 2013 and held it in 13 quarters. The position peaked at $6.59M in Q4 2013. 150 funds tracked by Wall St. Rank hold PMC as of Q3 2017.

  • TFS Capital reported no remaining PharMerica Corporation position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 8,222 PharMerica Corporation shares in Q3 2017, an estimated $216K.
  • TFS Capital first reported a position in PharMerica Corporation in Q2 2013 and held it in 13 quarters.
  • TFS Capital's PharMerica Corporation position peaked at $6.59M in Q4 2013.
  • 150 funds tracked by Wall St. Rank held PharMerica Corporation as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.